- Home
- ORGO
as 03-31-2025 4:00pm EST
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | CANTON |
| Market Cap: | 665.8M | IPO Year: | N/A |
| Target Price: | $5.50 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.17 - $6.71 | Next Earning Date: | 05-08-2025 |
| Revenue: | $482,043,000 | Revenue Growth: | 11.29% |
| Revenue Growth (this year): | -0.35% | Revenue Growth (next year): | 7.62% |
Stock Insider Trading Activity of Organogenesis Holdings Inc. (ORGO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Driscoll Michael Joseph | ORGO | Director | Mar 4 '25 | Sell | $5.10 | 25,000 | $127,535.00 | 166,879 |
Latest Organogenesis Holdings Inc. News
ORGO Breaking Stock News: Dive into ORGO Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
High Growth Tech Stocks Leading The US Market
Simply Wall St.
a month ago
High Growth Stocks Insiders Are Eager To Own
Simply Wall St.
a month ago
Organogenesis Holdings Full Year 2024 Earnings: Beats Expectations
Thomson Reuters StreetEvents
a month ago
Q4 2024 Organogenesis Holdings Inc Earnings Call
GuruFocus.com
a month ago
Organogenesis Holdings Inc (ORGO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Motley Fool
a month ago
Organogenesis (ORGO) Q4 2024 Earnings Call Transcript
Associated Press Finance
a month ago
Organogenesis: Q4 Earnings Snapshot
GlobeNewswire
a month ago
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
Compare ORGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORGO Organogenesis Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.